PHYHD1 Antibodies

Santa Cruz Biotechnology delivers a wide array of PHYHD1 monoclonal antibodies for research focused on understanding PHYHD1 protein function. PHYHD1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PHYHD1, or Phytanoyl-CoA 2-Hydroxylase Domain-Containing Protein 1, plays a crucial role in the metabolism of phytanic acid, which is important for maintaining cellular lipid homeostasis. Dysregulation of PHYHD1 has been implicated in various metabolic disorders, making it a significant target for research in lipid metabolism and related diseases. Understanding PHYHD1 function can provide insights into potential therapeutic strategies for conditions associated with lipid dysregulation. PHYHD1 monoclonal antibodies enable precise detection and analysis of PHYHD1 expression patterns across different tissues and experimental conditions. Researchers can utilize PHYHD1 monoclonal antibodies to examine protein localization, interactions, and modifications in cellular pathways. Santa Cruz Biotechnology monoclonal antibodies for PHYHD1 support researchers worldwide in advancing metabolic research and developing new therapeutic approaches.